Risk factors of tuberculosis after liver transplant in a tertiary care hospital

Autor: Mao-Wang Ho, Long Bin Jeng, Po-Chang Lin, Chia Huei Chou, Lih Ying Leong, Wei-Chih Liao, Jen Hsien Wang, Chih-Yu Chi, Min-Chi Lu
Rok vydání: 2021
Předmět:
Male
0301 basic medicine
Microbiology (medical)
medicine.medical_specialty
Tuberculosis
Opportunistic infection
medicine.medical_treatment
030106 microbiology
Population
Taiwan
Liver transplantation
Microbiology
Tertiary Care Centers
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
Immunology and Allergy
030212 general & internal medicine
education
Tuberculosis
Pulmonary

Survival rate
Aged
Retrospective Studies
education.field_of_study
General Immunology and Microbiology
business.industry
Incidence
TOR Serine-Threonine Kinases
Incidence (epidemiology)
Risk factors for tuberculosis
Immunosuppression
Mycobacterium tuberculosis
General Medicine
Middle Aged
medicine.disease
Transplant Recipients
QR1-502
Infectious Diseases
Risk factors
Case-Control Studies
Female
business
Zdroj: Journal of Microbiology, Immunology and Infection, Vol 54, Iss 2, Pp 312-318 (2021)
ISSN: 1684-1182
Popis: Background Tuberculosis (TB) is a serious opportunistic infection in liver transplant (LT) recipients with a high rate of morbidity and mortality. This study aims to clarify the frequency and risk factors for tuberculosis in LT recipients. Methods A total of 884 LT recipients were investigated retrospectively at China Medical University Hospital, Taichung, Taiwan. We performed a case–control study (1:2) to investigate the potential risk factors and disease onset of TB after LT. Results Among the 884 LT recipients, 25 of TB cases (2.8%) were reported from 2009 to 2016. The overall incidence of TB was 744 cases per 100,000 patient-year, which was 18-fold higher than the general population in Taiwan. The median time to develop TB after liver transplant was 20 months. Of the TB cases, 15 were pulmonary TB and 10 were extra-pulmonary TB. Five cases of those extra-pulmonary TB occurred in the first post-transplant year. Overall five-year survival rate was 63.3%. Multivariate analyses identified apical fibrotic change in pre-transplant computed tomographic (CT) finding and the exposure to mammalian target of rapamycin (mTOR) inhibitors before TB event as independent risk factors for TB development (Odd ratio (OR) 10.79, 95% confidence interval (CI), 1.73–67.49, p = 0.01; OR 3.847, 95% CI 0.80–18.51, P = 0.09, respectively). Conclusion TB incidence in LT recipients is high in this study. Among those post-transplant recipients with long-term immunosuppression, abnormal CT finding and exposure to mTOR inhibitors before liver transplant might be the risk factors for TB.
Databáze: OpenAIRE